Rights and permissions
About this article
Cite this article
FDA committee backs ‘Zoladex’ and ‘DOX-SL’. Inpharma Wkly. 976, 22 (1995). https://doi.org/10.2165/00128413-199509760-00056
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199509760-00056